Gland Pharma on Friday said its board has appointed Shyamakant Giri as chief executive officer with effect from Jan. 15, 2025. Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals, responsible for the commercial expansion and growth in India and Rest of the World markets.
Srinivas Sadu will continue to be the executive chairman of the company and support its next phase of growth, Gland Pharma said.
ADVERTISEMENT
RECOMMENDED FOR YOU
Finance Ministry Reports 1.4 Lakh New Jan Dhan Accounts In Two Weeks
Jul 15, 2025
Dealer Desk Buzz: FIIs, HNIs Active In Hindalco, Oriental Hotels, Gland Pharma And More
Jul 15, 2025
Stock Recommendations Today: TCS, HUL, Bharat Forge, Glenmark Pharma On Brokerages' Radar
Jul 11, 2025
Lutnick Says Trump’s Tariffs Will Take Effect On Aug. 1
Jul 07, 2025
POPULAR
1
Mumbai Rains Highlights: Rainfall Recedes After Heavy Downpour, Local Trains Running Smoothly
2
Planning To Study Abroad? Savings Plan To Scholarships — Expert Strategy To Manage Your Expenses
3
Tesla Versus Indian Peers: Here's How Model Y Compares With Mahindra XEV 9e, Tata Harrier.ev
4
Trade Talks: Trump Says Will Have Access Into India, Working On Same Line As Indonesia
5